Skip to main content
OpenTrials

Clinical trial condition

Coronary Restenosis

Explore clinical trials studying Coronary Restenosis. Study availability and eligibility vary by location and protocol.

58 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Coronary Restenosis trial results

Completed

To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels

NCT01977534

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +7 more
Locations
  • Lister Hospital Stevenage, Hertfordshire, United Kingdom
  • Basildon Hospital Basildon, United Kingdom
  • Royal Victoria Hospital Belfast, United Kingdom
  • Glan Clwyd District General Hospital Bodelwyddan, United Kingdom
View all 24 locations
View Trial Details
Completed

XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan

NCT01086228

Conditions
Angina, Angina Pectoris, Arterial Occlusive Diseases, +18 more
Locations
  • Site Reference ID/Investigator# 104727 Aichi, Japan
  • Site Reference ID/Investigator# 113428 Aichi, Japan
  • Site Reference ID/Investigator# 115745 Aichi, Japan
  • Site Reference ID/Investigator# 104424 Chiba, Japan
View all 47 locations
View Trial Details
Completed

ABSORB EXTEND Clinical Investigation

NCT01023789

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Disease, +9 more
Locations
  • Instituto Cardiovascular de Buenos Aires-ICBA Buenos Aires, Argentina
  • Eastern Heart Clinic, The Prince of Wales Hospital Randwick, New South Wales, Australia
  • Wesley Hospital Auchenflower, Queensland, Australia
  • St. Vincent's Hospital Melbourne, Victoria, Australia
View all 56 locations
View Trial Details
Completed

ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

NCT01583608

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +7 more
Locations
  • Medical Care Center Prof. Mathey, Prof. Schofer GmbH Hamburg, Free and Hanseatic City of Hamburg, Germany
  • Herzzentrum Brandenburg in Bernau Bernau, Germany
  • Klinikum Coburg GmbH Coburg, Germany
  • Elisabeth-Krankenhaus Essen GmbH Essen, Germany
View Trial Details
Completed

Clinical Performance of the Pantera Lux Balloon Versus the Orsiro Stent in Patients With In-stent Restenosis.

NCT01651390

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +7 more
Locations
  • Universitäts-Herzzentrum Freiburg-Bad Krozingen Bad Krozingen, Germany
  • Heart Center Segeberger Kliniken Bad Segeberg, Germany
  • Charité - Universitätsmedizin Berlin, Charité Centrum 11 für Herz-, Kreislauf- und Gefäßmedizin Berlin, Germany
  • Innere Medizin Kardiologie - Charité Centrum 11, Campus Benjamin Franklin Berlin, Germany
View all 14 locations
View Trial Details
Completed

SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)

NCT01171820

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +7 more
Locations
  • Salzburger Landeskliniken Salzburg, Austria
  • C.H.U. - Hopital Michallon Grenoble, France
  • CHU Lille - Hôpital Cardiologique Lille, France
  • Herzzentrum Bernau, Germany
View all 28 locations
View Trial Details

Related conditions